Advanced search
Publication Cover
Leukemia & Lymphoma Volume 43, 2002 - Issue 2
Submit an article Journal homepage
44
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Immune Complexes and Apoptosis in B-cell Chronic Lymphocytic Leukemia

Romina Gamberale Laboratorio de Immunología, Instituto de Investigaciones Hematológicas, Academia de Medicina, Pacheco de Melo 3081-1425, Buenos Aires, Argentina
,
Jorge R. Geffner Laboratorio de Immunología, Instituto de Investigaciones Hematológicas, Academia de Medicina, Pacheco de Melo 3081-1425, Buenos Aires, Argentina
&
Mirta Giordano Laboratorio de Immunología, Instituto de Investigaciones Hematológicas, Academia de Medicina, Pacheco de Melo 3081-1425, Buenos Aires, Argentina
Pages 251-255 | Published online: 01 Jul 2009

  • The French Cooperative Group on CLLDighiero, G., Travade, P., Chevret, S., Fenaux, P.,Chastang, C. and Binet, J.L. (1991) "B-cell chronic Iymphocytic leukemia: present status and futurc directions". Blood 78, 1901-1911.
  • Hamblin, T.J. and Oscier, D.G. (1997) "Chronic Iymphocytic leukaemia: the nature of the leukaemic cell". Blood Rev. 11, 119-128.
  • Caligaris-Cappio, F. and Hamblin. T. J. (1999) "B-cell chronic Iymphocytic leukemia: a bird of a different feather", J. Clin. Oncol. 17, 399-408.
  • Schena, M., Larsson, L.G., Gottardi, D., Gaidano, G., Carlsson, M., Nilsson, K. and Caligaris-Cappio, F. (1992) "Growth and differentiation-associated expression of bcl-2 in B-chronic lymphocytic leukemia cells". Blood 79, 2981-2989.
  • Robertson, L.E., Plunkett, W., McConnell, K., Keating, M.J. and McDonnell. T.J. (1996) "Bcl-2 expression in chronic Iymphocytic leukemia and its correlation with the induction of apoptosis and clinical outcome". Leukemia 10, 456-459.
  • Gottardi, D., Alfarano, A., DeLeo, A. M., Stacchini, A., Aragno, M., Rigo, A., Veneri, D., Zanotti, R., Pizzolo, G. and Caligaris-Cappio, f. (1996) "In leukemic CD5+B cells the expression of BCL-2 gene family is shifted toward protection form apoptosis", Br. J. Haematol, 94, 612-618.
  • Kitada, S., Andersen, J., Akar, S., Zapata, J. M., Takayama, S., Krajewski, S., Wang, H. G., Zhang, X., Bullrich, F., Croce, C. M., Rai, K., Hines, J. and Reed, J. C. (1998) "expression of apoptosisregulation proteins in chronic lymphocytic leukemia: correlations with in vitro and in vivo chemoresponses", Blood 91, 3379-3384.
  • Boumsell, L., Bernard, A., Lepage, V., Degos, L., lemerle, J. and Dausset, J. (1978) "Some chronic lymphocytic leukemia cells bearing surface immunoglobulins share determinants with T cells", Eur. J. Immunol. 8, 900-904.
  • Kilo, M. and Dorfman, D. M. (1996) "The utility of flow cytometric immunophenotypic analysis in the distinction of small lymphocytic lymphoma/chronic lymphocytic leukemia from mantle cell lymphoma", Am. J. Clin. Pathol, 105, 451-457.
  • Borche, L., Lim, A., Binet, J. L. and Dighiero, G. (1990) "Evidence that chronic lymphocytic leukemia B lymphocytes are frequently committed to production of natural autoantibodies". Blood 76, 562-569.
  • Schroeder, H. W. and Dighiero, G. (1994) "The pathogenesis of chronic lymphocytic leukemia: analysis of the antibody repertoire", Immunol. Today 15, 288-294.
  • Efremov, D., Ivanovsky, M. and Burrone, O. R. (1998) "The pathologic significance of the immunoglobulins expressed by chronic lymphocytic leukemia B-cells in the development of autoimmune hemolytic anemia", Leuk. Lymphoma 28, 285-291.
  • Nilsson, K. (1992) "The control of growth and differentiation in chronic lymphocytic leukemia (B-CLL) cells", In: Cheson, B. D., ed. Chronic lymphocytic leukemia: Scientific Advances and Clinical Development (Marcel Dekker, New York), pp 33-45.
  • Lankester, A. C., van Schijndel, G. M. W., van der Schoot, C. E., van Oers, M. H. J., van Noesel, C. J. M. and van Lier, R. A. W. (1995) "Antigen receptor nonresponsiveness in chronic lymphocytic leukemia B cells", Blood 86, 1090-1097.
  • Michel, F., Merle-Beral, h., Legac, E., Michel, A., Debre, P. and Bismuth, G. (1993) "Defective calcium response in B-chronic lymphocytic leukemia cells", J. Immunol. 150, 3624-3633.
  • Caligaris-Cappio, F. (1996) "B-chronic lymphocytic leukemia: a malignancy of anti-self B cells", Blood 87, 2615-2620.
  • Collins, R. J., Verschuer, L. A., Harmon, B. V., Prentice, R. L., Pope, J. H. and Kerr, J. F. (1989) "spontaneous programmed death (apoptosis) of B-chronic lymphocytic leukaemia cells following their culture in vitro", Br. J. Haematol, 71, 343-350.
  • McConkey, D. J., Aguilar-santelises, M., Hartzell, O., Eriksson, I., Mellstedt, H., Orrenius, S. and Jondall, M. (1991) "Induction of DNA fragmentation in chronic B-lymphocytic leukemia cells", J. Immunol. 146, 1072-1076.
  • Nilsson, J., Söderberg, O., Nilsson, K. and Rosén, A. (2000) "Thioredoxin prolongs survival of B-type chronic lymphocytic leukemia cells", Blood 95, 1420-1426.
  • Dancescu, M., Rubio-Trujillo, M., Biron, G., Bron, D., Delespesse, G. and Sarfati, M. (1992) "IL-4 protects chronic lymphocytic leukemic B cells from death by apoptosis and upregulated bcl-2 expression", J. exp. Med. 176, 1319-1326.
  • Mainou-Fowler, T., Craig, V. A., Copplestone, J. A., Hamon, M. D. and Prentice, A. G. (1994) "Interleukin-5 (IL-5) increases spontaneous apoptosis of B-cell chronic lymphocytic leukemia cells in vitor independently of bcl-2 expression and is inhibited by IL-4", Blood 84, 2297-2304.
  • Francia de Celle, P., Mariani, S., Riera, L., Stacchini, A., Reato, G. and Foa, R. (1996) "Interleukin-8 induces the accumulation of B-Cell chronic lymphocytic leukemia cells by prolonging survival in an autocrine fashion", Blood 87, 4382-4389.
  • Chaouchi, N., Wallon, C., Taieb, J., Auffredou, M. T., Tertian, G., Lemoine, F. M., Delfraissy, J. f. and Vazquez, A. (1994) "Interferon-a-mediated prevention on in vitro apoptosis of chronic lymphocytic leukemia B cells: role of bcl-2 and c-myc", Clin. Immunol, Immunopathol. 73, 197-203.
  • Panayiotidis, P., Ganeshaguru, K., Jabbar, S. A. and Hoffbrand, A. V. (1994) "Alpha-interferon (alpha-IFN) protects B-chronic lymphocytic leukaemia cells from apoptotic cell death in vitro", Br. J. Haematol, 86, 169-173.
  • Buschle, M., Campana, D., Carding, S. R., Richard, C., Hoffbrand, A. V. and Brenner, M. K. (1993) "Interferon ? inhibits apoptotic cell death in B cell chronic lymphocytic leukemia", J. Exp. Med. 177, 213-218.
  • Furman, R. R., Asgary, Z., mascarenhas, J. O., Liou, H. C. and Schattner, E. J. (2000) "Modulation of NF-kappa B activity and apoptosis in chronic lymphocytic leukemia B cells", J. Immunol. 164, 2200-2206.
  • Lagneaux, L., Delforge, A., Bron, D., De Bruyn, C. and Stryckmans, P. (1998) "Chronic lymphocytic leukemic B cells but not normal B cells are rescued from apoptosis by contact with normal bone marrow stromal cells", Blood 91, 2387-2396.
  • Burger, J. A., Tsukada, N., Burger, M., Zvaifler, N. J., Dell' Aquila, M. and Kipps, T. J. (2000) "Blood-derved nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1", Blood 96, 2655-2663.
  • Ravetch, J. V. (1997) "Fc receptors", Curr. Opin, Immunol. 9, 121-125.
  • Daëron, M. (1997) "Fc receptors biology", Annu. Rev. Immunol. 15, 203-234.
  • Yashwant, M. D., Graziano, R. F., Repp, R. and van de Winkel, J. G. J. (1997) "Clinical significance of IgG Fc receptors and Fc?R-directed immunotherapies", Immunol. Today 18, 127-135.
  • Amigorena, S., Bonnerot, C., Drake, J. R., Choquest, D., Hunziker, W., Guillet, J-G., Webster, P., Sautes, C., Mellman, I. and fridman, W. H. (1992) "Cytoplasmic domain heterogeneity and functions of IgG Fc receptors in B lymphocytes", Science 256, 1808-1813.
  • Brooks, D., Qui, W. Q., Luster, A. D. and Ravetch, J. V. (1989) "Structure and expression of human IgG Rfc?II (CD32): functional heterogeneity is encoded by alternatively spliced product of multiple genes", J. Exp. Med. 170, 1369-1385.
  • Cambier, J. C. (1995) "Antigen and Fc receptor signaling: the awesome power of the immunoreceptor tyrosine based activation motif (ITAM)", J. Immunol. 155, 3281-3285.
  • Vivier, E. and Daeron, M. (1997) "Imunoreceptor tyrosine-based inhibition motifs", Immunol. Today 18, 286-291.
  • Ravetch, J. V. and Lanier, L. L. (2000) "Immune inhibitory receptors", Science 290, 84-89.
  • Ravetch, J. V., Luster, A. D., Weinshank, R., Kochan, J., Pavlovec, A., Portnoy, D. A., Hulmes, J., Pan, Y. C. and Unkeless, J. C (1986) "Structural heterogeneity and functional domains of murine immunoglobulin G Fc receptors", Science 234, 718-725.
  • Warmerdam, P. A. M., van den HerikpOudijk, I. E., Parren, P. W. H. L. Westerdaal, N. A. C., van de Winkel, J. G. J. and Capel, P. J. A. (1993 "Interaction of a human Fc?RIIbl (CD32) isoform with murine and human IgG subclasses", Int. Immunol. 5, 239-247.
  • Van Den Herik-Oudijk, I. E., Westerdaal, N. A. C., henriquez, N. V., Capel, P. J. A. and Van de Winkel, J. G.J. (1994) "Functional analysis of human Fc?RII (CD32) isoforms expressed in B lymphocytes", J. Immunol. 152, 574-585.
  • Daëron, M., Latour, S., Malbec, O., Espinosa, E., Pivia, P., Pasmans, S. and Fridman, W. H. (1995) "The same tyrosine-based inhibition motif, in the intracytoplasmic domain of Fc?RIIB, regulates negatively BCR-, TCR- and FcR-dependent cell activation", Immunity 3, 635-646.
  • Takai, T., Ono, M., Hikida, M., Ohmori, H. and Ravetch, J. V. (1996) "Augmented humoral and anaphylactic responses in Fe gamma RII deficient mice", Nature 379, 346-349.
  • clynes, R., Maizes, J. S., Guinamard, R., Ono, M., Takai, T. and Ravetch, J. V. (1999) "Modulation of immune complex-induced inflammation in vivo by the coordinate expression of activation and inhibitory Fc receptors", J. exp. Med. 189, 179-185.
  • Yuasa, T., Kubo, S., Yoshino, T., Ujike, A., Matsumura, K., Ono, M., Ravetch, J. V. and Takai, T. (1999) "Deletion of Fc?RIIB renders H-2b mice susceptible to collagen-induced arthritis", J. Exp. Med. 189, 187-194.
  • Ortaldo, J. R., Mason, A. T. and O'shea, J. J. (1995) "receptor-induced death in human natural killer cells: involvement of CD16", J. Exp. Med. 181-339-344.
  • Gamberale, R., Giordano, M., Trevani, A., Andonegui, G. and Geffner, J. R. (1998) "Modulation of human neutrophil apoptosis by immune complexes", J. Immunol 161, 3666-3674.
  • Kim, J. -T., Schimming, A. W. and Kita, H. (1999) "Ligation of Fc?RII (CD32) pivotally regulates survival of human eosinophils", J. Immunol. 162, 4253-4259.
  • Pearse, R. N., Kawabe, T., Bolland, S., Guinamard, R., Kurosaki, T. and Ravetch, J. V. (1999) "SHIP recruitment attenuates Fc?RIIB-induced B cell apoptosis", Immunity 10, 753-760.
  • Carpentier, N. A., Louis, J. A., Lambert, P. H., and Cerottini, J. C. (1981) "Immune complexes in leukemia and adult malignancies", In: Serrou, B. and Rosenfeld, C., eds, Immune Complexes and Plasma Exchanges in Cancer Patients (Elsevier/North-Holland Biomedical Press, Amsterdam), pp 111-123.
  • Day, N. K., Good, R. A. and Witkin, S. S. (1981) "Circulating immune complexes and complement in human malignancy", In: Serrou, B. and Rosenfeld, C., eds. Immune complexes and Plasma Exchanges in Cancer patients (Elsevier/North-Holland Biomedical Press, Amsterdam), pp 99-110.
  • Garvey, M. B. and Freedman, J. (1986) "Indirect platelet radioactive antiglobulin test in patients with lymphoproliferative disease", J. Lab. Clin. Med. 107, 123-128.
  • Dighiero, G. (1998) "Chronic lymphocytic leukemia treatment", Hematol. Cell Ther. 39, S31-S40.
  • Begleiter, A., Mowat, M., israels, L. G. and Johnston, J. B. (1996) "Chlorambucil in chronic lymphocytic leukemia: mechanism of action". Leuk. Lymphoma 23, 187-201.
  • Shenkerman, G., Klaper, R., Ness-Abramof, R., Vishlitzky, V., Zemer, R., Ellis, M., Lishner, M., Manor, Y., Yukea, M., Shenkman, L. and Klein, A. (1997) "Induction of apoptosis by chlorodeoxyadenosine and dexamethasone in B-chronic lymphocytic leukemia", Leuk, Lymphoma 28, 153-157.
  • Gamberale, R., Geffner, J. R., Trevani, A., chernavsky, A., Scolnik, M., Arrosagaray, G., Sarmiento, M. and Giordano, M. (1999) "Immune complexes inhibit apoptosis of chronic lymphocytic leukemia B cells", Br. J. Haematol. 107, 870-876.
  • Burton, D. R. and Woof, J. M. (1992) "Human antibody effector function", Adv Immunol. 51, 1-84.
  • Yuan, R., Clynes, R., Oh, J., Ravetch, J. V. and /Scharff, M. D. (1998) "Antibody-mediated modulation of Cryptococcus neoformans infection is dependent on distinct Fc receptors functions and IgG subclasses", J. Exp. Med. 187, 641-648.
  • Sato, K. and Ochi, A. (1998) "Superclustering of B-cell receptor and Fc?RIIB 1 activates Src homology 2-containing protein tyrosine phosphatase-1", J. Immunol. 161, 2716-2722.
  • Dighiero, G. (1988) "An attempt to explain disordered immunity and hypogammaglobulinemia in CLL", Nouv. Rev. Fr. Hematol, 30, 283-286.
  • Lacombe, C., Gombert, J., Dreyfus, B., Brizard, A. and Preud' Homme, J. L. (1999) "Heterogeneity of serum IgG subclass deficiencies in B chronic lymphocytic leukemia", Clin. Immunol. 90, 128-132.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.